How Biogen Salvaged Alzheimer’s Drug After a Costly Failure

(Bloomberg) -- It was one of the most surprising and puzzling reversals in drug-industry history. Biogen Inc. said an Alzheimer’s treatment it had left for dead earlier this year may work after all.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.